Logo image of BON.PA

BONDUELLE SCA (BON.PA) Stock Fundamental Analysis

EPA:BON - Euronext Paris - Matif - FR0000063935 - Common Stock - Currency: EUR

8.12  -0.25 (-2.99%)

Fundamental Rating

3

Overall BON gets a fundamental rating of 3 out of 10. We evaluated BON against 57 industry peers in the Food Products industry. Both the profitability and financial health of BON have multiple concerns. BON is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year BON has reported negative net income.
BON had a positive operating cash flow in the past year.
Of the past 5 years BON 4 years were profitable.
BON had a positive operating cash flow in 4 of the past 5 years.
BON.PA Yearly Net Income VS EBIT VS OCF VS FCFBON.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

BON has a worse Return On Assets (-6.06%) than 82.46% of its industry peers.
Looking at the Return On Equity, with a value of -21.14%, BON is doing worse than 80.70% of the companies in the same industry.
BON's Return On Invested Capital of 5.16% is in line compared to the rest of the industry. BON outperforms 56.14% of its industry peers.
BON had an Average Return On Invested Capital over the past 3 years of 3.87%. This is below the industry average of 6.38%.
The last Return On Invested Capital (5.16%) for BON is above the 3 year average (3.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -6.06%
ROE -21.14%
ROIC 5.16%
ROA(3y)-1.26%
ROA(5y)0.26%
ROE(3y)-4.23%
ROE(5y)0.55%
ROIC(3y)3.87%
ROIC(5y)4%
BON.PA Yearly ROA, ROE, ROICBON.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

With a Operating Margin value of 3.73%, BON perfoms like the industry average, outperforming 45.61% of the companies in the same industry.
BON's Operating Margin has declined in the last couple of years.
The Gross Margin of BON (28.41%) is worse than 71.93% of its industry peers.
In the last couple of years the Gross Margin of BON has remained more or less at the same level.
Industry RankSector Rank
OM 3.73%
PM (TTM) N/A
GM 28.41%
OM growth 3Y7.56%
OM growth 5Y-6.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y0.61%
BON.PA Yearly Profit, Operating, Gross MarginsBON.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

2

2. Health

2.1 Basic Checks

BON has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BON has about the same amout of shares outstanding than it did 1 year ago.
BON has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, BON has a worse debt to assets ratio.
BON.PA Yearly Shares OutstandingBON.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BON.PA Yearly Total Debt VS Total AssetsBON.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 1.91 indicates that BON is not a great score, but indicates only limited risk for bankruptcy at the moment.
BON's Altman-Z score of 1.91 is in line compared to the rest of the industry. BON outperforms 45.61% of its industry peers.
A Debt/Equity ratio of 0.88 indicates that BON is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.88, BON is doing worse than 68.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Altman-Z 1.91
ROIC/WACC1
WACC5.13%
BON.PA Yearly LT Debt VS Equity VS FCFBON.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

BON has a Current Ratio of 1.33. This is a normal value and indicates that BON is financially healthy and should not expect problems in meeting its short term obligations.
BON has a Current ratio of 1.33. This is comparable to the rest of the industry: BON outperforms 47.37% of its industry peers.
A Quick Ratio of 0.43 indicates that BON may have some problems paying its short term obligations.
BON has a Quick ratio of 0.43. This is amonst the worse of the industry: BON underperforms 82.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.43
BON.PA Yearly Current Assets VS Current LiabilitesBON.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

2

3. Growth

3.1 Past

BON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -8526.77%.
Looking at the last year, BON shows a decrease in Revenue. The Revenue has decreased by -1.04% in the last year.
BON shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.11% yearly.
EPS 1Y (TTM)-8526.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.38%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y3.11%
Revenue growth 5Y-3.11%
Sales Q2Q%-1.74%

3.2 Future

BON is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.83% yearly.
BON is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.07% yearly.
EPS Next Y-1.1%
EPS Next 2Y20.04%
EPS Next 3Y19.83%
EPS Next 5YN/A
Revenue Next Year-6.23%
Revenue Next 2Y-2.15%
Revenue Next 3Y-0.62%
Revenue Next 5Y2.07%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BON.PA Yearly Revenue VS EstimatesBON.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
BON.PA Yearly EPS VS EstimatesBON.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BON. In the last year negative earnings were reported.
BON is valuated cheaply with a Price/Forward Earnings ratio of 6.43.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BON indicates a rather cheap valuation: BON is cheaper than 91.23% of the companies listed in the same industry.
BON's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE N/A
Fwd PE 6.43
BON.PA Price Earnings VS Forward Price EarningsBON.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BON is valued cheaply inside the industry as 98.25% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.2
BON.PA Per share dataBON.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as BON's earnings are expected to grow with 19.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.04%
EPS Next 3Y19.83%

More info and screens

2

5. Dividend

5.1 Amount

BON has a Yearly Dividend Yield of 2.36%. Purely for dividend investing, there may be better candidates out there.
BON's Dividend Yield is comparable with the industry average which is at 3.19.
Compared to an average S&P500 Dividend Yield of 2.40, BON has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.36%

5.2 History

The dividend of BON decreases each year by -1.50%.
Dividend Growth(5Y)-1.5%
Div Incr Years0
Div Non Decr Years0
BON.PA Yearly Dividends per shareBON.PA Yearly Dividends per shareYearly Dividends per share 2018 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of BON are negative and hence is the payout ratio. BON will probably not be able to sustain this dividend level.
DP-6.39%
EPS Next 2Y20.04%
EPS Next 3Y19.83%
BON.PA Yearly Income VS Free CF VS DividendBON.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

More info and screens

BONDUELLE SCA

EPA:BON (6/19/2025, 7:00:00 PM)

8.12

-0.25 (-2.99%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-06 2025-05-06
Earnings (Next)08-01 2025-08-01/amc
Inst Owners7.04%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap264.96M
Analysts73.33
Price Target8.89 (9.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.36%
Yearly Dividend0.26
Dividend Growth(5Y)-1.5%
DP-6.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.43
P/S 0.12
P/FCF N/A
P/OCF 3.86
P/B 0.43
P/tB 0.82
EV/EBITDA 3.2
EPS(TTM)-4.03
EYN/A
EPS(NY)1.26
Fwd EY15.55%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)2.11
OCFY25.94%
SpS69.82
BVpS18.75
TBVpS9.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.06%
ROE -21.14%
ROCE 7.24%
ROIC 5.16%
ROICexc 5.23%
ROICexgc 6.9%
OM 3.73%
PM (TTM) N/A
GM 28.41%
FCFM N/A
ROA(3y)-1.26%
ROA(5y)0.26%
ROE(3y)-4.23%
ROE(5y)0.55%
ROIC(3y)3.87%
ROIC(5y)4%
ROICexc(3y)4%
ROICexc(5y)4.09%
ROICexgc(3y)5.96%
ROICexgc(5y)6.3%
ROCE(3y)5.42%
ROCE(5y)5.61%
ROICexcg growth 3Y14.41%
ROICexcg growth 5Y-8.74%
ROICexc growth 3Y19.99%
ROICexc growth 5Y-5.6%
OM growth 3Y7.56%
OM growth 5Y-6.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y0.61%
F-Score4
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Debt/EBITDA 1.76
Cap/Depr 35.89%
Cap/Sales 3.5%
Interest Coverage 250
Cash Conversion 22.37%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 0.43
Altman-Z 1.91
F-Score4
WACC5.13%
ROIC/WACC1
Cap/Depr(3y)55.81%
Cap/Depr(5y)69.55%
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8526.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.38%
EPS Next Y-1.1%
EPS Next 2Y20.04%
EPS Next 3Y19.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y3.11%
Revenue growth 5Y-3.11%
Sales Q2Q%-1.74%
Revenue Next Year-6.23%
Revenue Next 2Y-2.15%
Revenue Next 3Y-0.62%
Revenue Next 5Y2.07%
EBIT growth 1Y33.82%
EBIT growth 3Y10.9%
EBIT growth 5Y-9.45%
EBIT Next Year1309.91%
EBIT Next 3Y146.14%
EBIT Next 5Y75.84%
FCF growth 1Y-71.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.64%
OCF growth 3YN/A
OCF growth 5YN/A